// App-Quantinova.ai

OP037 : Three-year results from the multicentre PROMUS Element European post-approval (PE-Prove) registry: outcomes in 1,010 unselected patients treated with a platinum-chromium, everolimus-eluting stent

Researchers

Presenter

  • Moreno R

Principal Investigators

  • Werner G.S

  • Barragan P

  • Berger R

  • Kinnaird T

  • Schaefer A

  • Clarke S.C

  • Benit E

  • Fabbiocchi F

  • Christen T

  • Dawkins K.D

Medical Centers

  • Hospital La Paz, Madrid, Spain

  • Division of Oncology, Medical University of Graz, Graz, Austria

  • Jessaziekenhuis, Hasselt, Belgium

  • University Hospital of Wales, Cardiff, United Kingdom

  • Centro Cardiologico Monzino IRCCS, Milan, Italy

  • Medizinische Klinik I, Klinikum Darmstadt GmbH, Darmstadt, Germany

  • Medizinische Hochschule Hannover, Hannover, Germany

  • Centre de Radiologie Cardio-Vasculaire et Interventionnelle-CRCVI, Ollioules, France

  • Papworth Hospital, Cambridge, United Kingdom

Locations

  • Italy

  • Austria

  • Spain

  • Germany

  • United Kingdom

  • France

  • Belgium

Companies

  • Boston Scientific

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Chronic total occlusion

  • Myocardial infarction

  • Angina

  • Venous thrombosis

  • Diabetes

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • Promus Element

  • Everolimus

Outcome

  • N/A

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved